EntryPoint Capital’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$603K Sell
70,397
-48,103
-41% -$339K 0.15% 247
2026
Q1
$763K Buy
118,500
+92,476
+355% +$715K 0.22% 110
2025
Q4
$213K Sell
26,024
-11,218
-30% -$101K 0.08% 526
2025
Q3
$330K Buy
+37,242
New +$235K 0.13% 326
2025
Q2
Sell
-12,238
Closed -$66.3K 616
2025
Q1
$66.3K Sell
12,238
-2,614
-18% -$12.3K 0.03% 636
2024
Q4
$67.9K Buy
+14,852
New +$76.1K 0.03% 683

Other funds holding AVAH

EntryPoint Capital's AVAH Position: Q2 2026 in Review

EntryPoint Capital reduced its Aveanna Healthcare (AVAH) stake by 41% in Q2 2026, selling an estimated $339K and leaving 70,397 shares worth $603K. The position accounts for 0.15% of the portfolio, ranked #247.

EntryPoint Capital first reported a position in AVAH in Q4 2024 and has held it in 6 quarters since. The position peaked at $763K in Q1 2026. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • EntryPoint Capital held 70,397 shares of Aveanna Healthcare worth $603K as of Q2 2026.
  • EntryPoint Capital sold 48,103 Aveanna Healthcare shares in Q2 2026, an estimated $339K.
  • Aveanna Healthcare made up 0.15% of EntryPoint Capital's portfolio in Q2 2026, its #247 holding.
  • EntryPoint Capital first reported a position in Aveanna Healthcare in Q4 2024 and has held it in 6 quarters since.
  • EntryPoint Capital's Aveanna Healthcare position peaked at $763K in Q1 2026.
  • 215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.